Sirolimus Solution
Product Images NDC 31722-316

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 16 technical images submitted to the FDA as part of the official labeling for Sirolimus (NDC 31722-316). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Camber Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Camber-logo-2 (Camber Logo 2)

FDA Label Image

Camber-logo-3 (Camber Logo 3)

FDA Label Image
FDA Label Image

Figure1 (Figure1)

Figure1 (Figure1)
A line graph showing FEV1 (liters) over a 24-month period during Treatment Phase and Observation Phase for Sirolimus versus placebo groups. The graph includes data points with error bars at multiple months, illustrating lung function trends for 46 Sirolimus subjects and 43 placebo subjects initially, with subject numbers decreasing over time.*
FDA Label Image

Sirolimuscontainer (Sirolimuscontainer)

Sirolimuscontainer (Sirolimuscontainer)
Label for Sirolimus Oral Solution 1 mg/mL by Camber Pharmaceuticals, Inc. The 60 mL bottle label includes the NDC 31722-316-60, storage instructions, light protection warning, and pharmacist dispensing note. The product is for oral use only and includes contact and manufacturing details.*
FDA Label Image

Sirolimusinnercarton (Sirolimusinnercarton)

Sirolimusinnercarton (Sirolimusinnercarton)
Packaging label for Sirolimus Oral Solution 1 mg/mL by Camber Pharmaceuticals, Inc. The label specifies a 60 mL bottle, oral use only, containing 1 mg Sirolimus per mL. The label includes storage instructions to refrigerate at 2° to 8°C, keep out of reach of children, protect from light, and use within 1 month after opening. The label also lists inactive ingredients and manufacturer information for Camber Pharmaceuticals, with contact details and a web link for the medication guide.*
FDA Label Image

Sirolimusoutercarton (Sirolimusoutercarton)

Sirolimusoutercarton (Sirolimusoutercarton)
Packaging label for Sirolimus Oral Solution 1 mg/mL by Camber Pharmaceuticals, Inc. The 60 mL patient kit contains a 2 oz. glass bottle with 1 mg/mL sirolimus solution, an oral syringe adapter, 30 oral syringes and caps, and a carrying case. The label includes usage instructions, storage at 2° to 8°C, and a U.S. contact number.*
FDA Label Image

Sirolimuspicture1 (Sirolimuspicture1)

Sirolimuspicture1 (Sirolimuspicture1)
An instructional illustration showing the contents included with the SIROLIMUS oral solution packaging. It depicts a vial (a), a dropper attachment (b), two syringes with measurement markings (c), and a box (d) for storing these items. The parts appear assembled for preparation or dosing of the solution.*
FDA Label Image

Sirolimuspicture2 (Sirolimuspicture2)

Sirolimuspicture2 (Sirolimuspicture2)
An instructional illustration showing a hand gripping the cap of an oral solution bottle, with an arrow indicating the direction to turn the cap. The bottle is unlabeled and plain.*
FDA Label Image

Sirolimuspicture3 (Sirolimuspicture3)

Sirolimuspicture3 (Sirolimuspicture3)
An instructional illustration showing a hand pressing down on the top of an oral solution bottle, likely demonstrating how to open or activate the container for the sirolimus 1 mg/mL oral solution by Camber Pharmaceuticals, Inc.*
FDA Label Image

Sirolimuspicture4 (Sirolimuspicture4)

Sirolimuspicture4 (Sirolimuspicture4)
An instructional diagram showing how to draw solution from a vial using a syringe. The left panel illustrates pressing down on the syringe plunger. The right panel depicts inserting the syringe into a vial and pulling the plunger upwards to draw the liquid.*
FDA Label Image

Sirolimuspicture5 (Sirolimuspicture5)

Sirolimuspicture5 (Sirolimuspicture5)
An instructional illustration showing hands preparing an oral solution dose of sirolimus using a syringe. The image depicts the syringe being inserted into the bottle and a close-up inset demonstrating the syringe measurement markings. This aids in accurate dosing of the sirolimus oral solution.*
FDA Label Image

Sirolimuspicture6 (Sirolimuspicture6)

Sirolimuspicture6 (Sirolimuspicture6)
An instructional line drawing showing a hand holding a syringe while the other hand attaches or adjusts the syringe cap or needle. The arrow indicates the direction to remove or position the attachment on the syringe. This likely demonstrates preparation or administration steps for an oral solution dose.*
FDA Label Image

Sirolimuspicture7 (Sirolimuspicture7)

Sirolimuspicture7 (Sirolimuspicture7)
An instructional diagram showing a hand holding a syringe positioned above a rectangular testing device with a sample well, illustrating the process of applying a liquid sample to the device.*
FDA Label Image

Sirolimuspicture8 (Sirolimuspicture8)

Sirolimuspicture8 (Sirolimuspicture8)
An instructional illustration showing a syringe dispensing liquid into a small cup. The image likely demonstrates the transfer or measurement of an oral solution dose.*
FDA Label Image

Sirolimusstructure (Sirolimusstructure)

Sirolimusstructure (Sirolimusstructure)
Chemical structure of sirolimus depicted as a 2D skeletal formula showing its complex macrocyclic lactone ring with multiple functional groups including hydroxyls, carbonyls, and methoxy substituents.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.